Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

Regeneron Pharmaceuticals (REGN) Stock Price Prediction and News Highlight
Fri. Jan 2, 2026

The price action of Regeneron Pharmaceuticals (REGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.4 is modestly bearish. The market sentiment at 0.8 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for REGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.9, and the negative at -0.1 on 2026-01-02. The forces of Stock Price Trend (-0.4), Sentiment towards Fundamentals (-0.3), and Sector Price Trend (-0.3) will drive down the price. The forces of Price Level Sentiment (0), Market Risk Appetite (0.4), Option Sentiment (1.5), and Valuation Sentiment (3.2) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.


Earning Release: 2026-01-30 05:00, EPS: $41.76, P/E: 18.59

REGN
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2026-01-020%(0%)      776.31 72    0.58%    0.34%    -0.4    0.03%    0.2%    0.7    Long    70%    -0.3    -1   
2026-01-010%(0%)    0.1    -0.09%    0.5          1.5    -1   
2025-12-310%(0%)      771.87 70    -0.27%    0.34%    0.1    -0.09%    0.4%    1.1    Wait    50%    2    -1   
2025-12-300%(0%)      773.94 73    -0.83%    0.27%    -0.5    -0.05%    0.5%    0.7    Short    70%    2    -1   
2025-12-290%(0%)      780.44 81    -0.58%    0.51%    1    -0.03%    0.3%    1.6    Wait    50%    3.4    -1   
2025-12-280%(0%)    1.5    0%    1          3.5    -1   
2025-12-270%(0%)    1.5    0%    0.9          3.5    -1   
2025-12-260%(0%)      784.97 85    0.16%    0.5%    1.5    0%    0.4%    1.4    Wait    50%    3.8    -1   
2025-12-250%(0%)    1.3    0.01%    1.8          4.4    -1   
2025-12-240%(0%)      783.71 84    -0.19%    0.77%    1.3    0.01%    0.4%    1.7    Wait    50%    4.1    -1   
 
Long is the preferred trading strategy with 70% chance of being right. The pullback is expected after the huge price pop today. The trend sentiment and hourly trend are not too bullish.

Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.

Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2026-01-02 17:10:22 The potential for continued growth in Regeneron's stock is discussed, with predictions of further increases driven by ongoing product success.
2026-01-02 17:10:22 Challenges faced by Outlook Therapeutics in developing new treatments highlight the difficulties in the pharmaceutical industry.
2026-01-02 17:10:22 Investor confidence appears strong for Regeneron, influenced by FDA approvals and robust product earnings.
2026-01-02 17:10:22 The FDA's rejection of Outlook Therapeutics' eye drug filing has a negative impact on its stock and raises concerns about future approvals.
2026-01-02 17:10:22 Articles indicate a positive trend in stock performance for Regeneron, citing a significant increase in share price.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA